The EBV Immunoevasins vIL-10 and BNLF2a Protect Newly Infected B Cells from Immune Recognition and Elimination

• Simon Jochum,

  Affiliation Research Unit Gene Vectors, Helmholtz Center, Munich, Germany

  ⨯
• Andreas Moosmann,

  Affiliation Clinical Cooperation Group Immunooncology, Helmholtz Center, Munich, Germany

  ⨯
• Stephan Lang,

  Affiliation Department of Otorhinolaryngology, Universitätsklinikum Essen, Essen, Germany

  ⨯
• Wolfgang Hammerschmidt,

  Affiliation Research Unit Gene Vectors, Helmholtz Center, Munich, Germany

  ⨯
• Reinhard Zeidler

  * E-mail: Reinhard.Zeidler@med.lmu.de

  Affiliation Ludwig-Maximilians-Universität, Department of Otorhinolaryngology, Munich, Germany

  ⨯